Trademark: 79144590
Word
GEMINI PHARMCHEM
Status Date
Sunday, December 3, 2023
Filing Date
Tuesday, December 3, 2013
Published for Opposition
Tuesday, June 23, 2015
Abandoned Date
Sunday, December 3, 2023
5 PHARMACEUTICAL AND VETERINARY PREPARATIONS FOR TREATING VARIOUS TYPES OF CANCERS, DISEASES OF THE IMMUNOLOGICAL SYSTEM, NAMELY, AUTO-IMMUNE DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, AND FOR PREVENTION OF ORGAN REJECTION AFTER TRANSPLANTATION, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; CHEMICAL PREPARATIONS FOR PHARMACEUTICAL USE, NAMELY, FOR TREATING CANCER AND ONCOLOGY DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; CHEMICAL REAGENTS FOR MEDICAL OR VETERINARY USE; PHARMACEUTICAL PREPARATIONS FOR MEDICAL USE FOR TREATING CANCER AND ONCOLOGY DISEASES, DISEASES OF THE ALIMENTARY TRACT, METABOLIC DISORDERS AND DISEASES, BLOOD DISEASES, DISEASES OF THE BLOOD FORMING ORGANS, DISEASES OF THE CARDIOVASCULAR SYSTEM, DERMATOLOGICAL DISEASES AND SKIN DISORDERS, DISEASES OF THE GENITO-URINARY SYSTEM AND SEX HORMONE DISORDERS, SYSTEMIC HORMONAL ABNORMALITIES, MUSCULO-SKELETAL SYSTEM DISEASES, NERVOUS SYSTEM DISEASES AND DISORDERS, RESPIRATORY SYSTEM DISEASES, DISEASES OF THE SENSORY ORGANS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY; ANTIBIOTICS; DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS; RADIOACTIVE SUBSTANCES FOR USE IN NUCLEAR MEDICINE; ANTIPARASITICS AND ANTIPARASITIC PREPARATIONS
35 BUSINESS MANAGEMENT SERVICES, NAMELY, REGULATORY SUBMISSION MANAGEMENT, NAMELY, ASSISTING OTHERS IN PREPARING AND FILING APPLICATIONS FOR DRUGS WITH GOVERNMENTAL REGULATORY BODIES; RETAIL SERVICES, NAMELY, RETAIL STORE SERVICES, MAIL ORDER SERVICES AND ON-LINE RETAIL STORE SERVICES FEATURING ACTIVE PHARMACEUTICAL INGREDIENTS, AND VETERINARY PREPARATIONS, CHEMICAL PREPARATIONS FOR PHARMACEUTICAL PURPOSES, PHARMACEUTICAL PREPARATIONS FOR MEDICAL PURPOSES, DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS, RADIOACTIVE SUBSTANCES FOR USE IN NUCLEAR MEDICINE, all of the aforementioned services only in relation to pharmaceuticals and chemicals
1 CHEMICALS FOR USE IN INDUSTRY AND SCIENCE, NAMELY, CHEMICAL PREPARATIONS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS, ACTIVE PHARMACEUTICAL INGREDIENTS FOR THE MANUFACTURE OF FINISHED PHARMACEUTICALS, ACTIVE CHEMICAL INGREDIENTS AND AGENTS FOR USE IN THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS, PHARMACEUTICALS, ANTIPARASITICS AND ANTIPARASITIC PREPARATIONS; PRESERVATIVES FOR PHARMACEUTICAL PREPARATIONS
42 scientific and technological services, namely, research, design, evaluations and engineering appraisals in the fields of chemical intermediates, active chemical ingredients provided by engineers and scientists; industrial analysis and research services in the field of chemical intermediates and active chemical ingredients; engineering; research in the field of chemical research; chemical analysis; chemistry services, namely, chemistry consultation, research in the field of chemistry, optimization of chemical processes, analysis for polymorphism determination; biological research; bacteriological research; physics research; chemical research, all of the aforementioned services only in relation to pharmaceuticals and chemicals
The mark consists of a design of a square composed of shaded circles with the roman numeral "II" appearing within the square in darker circles. To the left of the design is the stylized wording "GEMINI PHARMCHEM".
Color is not claimed as a feature of the mark.
Apr 8, 2014
Non-Final Action Written
Apr 3, 2014
Sn Assigned For Sect 66a Appl From Ib
Apr 4, 2014
New Application Office Supplied Data Entered
Apr 4, 2014
Assigned To Examiner
Apr 8, 2014
Application Filing Receipt Mailed
Oct 21, 2014
Final Refusal Written
Apr 9, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Apr 9, 2014
Refusal Processed By Mpu
Apr 9, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Apr 25, 2014
Refusal Processed By Ib
Sep 26, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 26, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 30, 2014
Teas Response To Office Action Received
Sep 30, 2014
Correspondence Received In Law Office
Sep 30, 2014
Teas/Email Correspondence Entered
Oct 21, 2014
Final Refusal E-Mailed
Oct 21, 2014
Notification Of Final Refusal Emailed
May 8, 2015
Examiners Amendment -Written
Apr 20, 2015
Teas Request For Reconsideration Received
Apr 20, 2015
Exparte Appeal Received At Ttab
Apr 20, 2015
Jurisdiction Restored To Examining Attorney
Apr 20, 2015
Ex Parte Appeal-Instituted
Apr 22, 2015
Assigned To Lie
Apr 22, 2015
Correspondence Received In Law Office
Apr 22, 2015
Teas/Email Correspondence Entered
May 8, 2015
Examiners Amendment E-Mailed
May 8, 2015
Notification Of Examiners Amendment E-Mailed
May 8, 2015
Examiner's Amendment Entered
Jun 3, 2015
Notification Of Possible Opposition Sent To Ib
Jun 20, 2015
Notification Processed By Ib
Jun 23, 2015
Published For Opposition
May 8, 2015
Approved For Pub - Principal Register
May 8, 2015
Exparte Appeal Terminated
May 19, 2015
Law Office Publication Review Completed
Jun 3, 2015
Notification Of Notice Of Publication E-Mailed
Jun 3, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 22, 2015
Irregularity On Refusal From Ib
Jun 23, 2015
Official Gazette Publication Confirmation E-Mailed
Jun 23, 2015
Extension Of Time To Oppose Received
Sep 9, 2015
Notification Of Possible Opposition Created, To Be Sent To Ib
Sep 9, 2015
Notification Of Possible Opposition Sent To Ib
Sep 25, 2015
Notification Of Possible Opposition - Processed By Ib
Oct 16, 2015
Opposition Notice (Ib Refusal) Created
Oct 16, 2015
Opposition Notice (Ib Refusal) Sent To Ib
Oct 19, 2015
Opposition Instituted No. 999999
Aug 31, 2018
Final Decision Transaction Processed By Ib
Nov 17, 2015
Refusal Processed By Ib
Dec 18, 2015
Limitation Of Goods Received From Ib
Mar 16, 2016
Limitation From The Ib Examined And Entered
Aug 3, 2017
Opposition Terminated No. 999999
Aug 3, 2017
Opposition Sustained No. 999999
Aug 3, 2017
Abandonment - After Inter Partes Decision
Aug 3, 2017
Abandonment Notice Mailed - Inter Partes Decision
Aug 3, 2018
Final Disposition Notice Created, To Be Sent To Ib
Aug 3, 2018
Final Disposition Notice Sent To Ib
Jun 23, 2024
Death Of International Registration
Jun 23, 2024
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
